Skip to main content

Advertisement

Table 2 Comparison of patients with and without primary care follow-up

From: Access to primary care is associated with better autoimmune hepatitis outcomes in an urban county hospital

  Full cohort Without PCa With PCa p
  N (%) N (%) N (%)  
n 83 57 26  
Treated 67 (81) 41 (72) 26 (100) 0.002
Not treated due to decompensation/Childs B or C disease 6 6 0  
Not treated because "No indication" according to clinician 2 2 0  
Not treated because LFTs or liver enzymes either were normal, insignificantly elevated, or resolved on own 5 5 0  
Unclear why not treated 2 2 0  
Patient to follow up with PC physician 1 1 0  
Remission 43 (52) 28 (49) 15 (58) 0.469
Noncompliance 10 (12) 6 (11) 4 (15) 1.000
Steroid median dose 40 (IQR 40–60) 40 (IQR 40–60) 40 (IQR 40–55) 0.535
Median time corticosteroids (months) 12 (14.5) 12 (IQR 5–23) 15 (IQR 12–28) 0.115
Median time to ALT normalization (months) 1.4 (IQR 0.8-3.3) 1.3 (IQR 0.8-3.7) 1.6 (IQR 0.6-2.9) 0.504
Relapses 23 (27) 12 (21) 11 (42) 0.380
  1. aPC = Primary Care (Defined as 6 months or greater of Internal Medicine and Family Medicine visit physician follow-up)